THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS) announced it will be a key sponsor of the National Multiple Sclerosis Society’s Walk MS series of events being held in the Houston area and Austin, Texas, during October and November.
Help employers find you! Check out all the jobs and post your resume.
